EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Neuroanatomical and cognitive biomarkers of alpha‐synuclein propagation in a mouse model of synucleinopathy prior to onset of motor symptoms

Stephanie Tullo iD, Aline S Miranda, Esther Del Cid-Pellitero, Mei Peng Lim, Daniel Gallino, Anoosha Attaran, Raihaan Patel, Vladislav Novikov, Megan Park, Flavio H Beraldo, Wen Luo, Irina Shlaifer und 7 weitere

Journal of Neurochemistry · 2024

DOI: 10.1111/jnc.15967 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neurochemistry, 2024. Verfasst von Stephanie Tullo und 18 weiteren Autor:innen. Beteiligte Einrichtung: Integrated Program in Neuroscience, McGill University, Montreal, Quebec, Canada. Hauptthemen laut MEDLINE: alpha-Synuclein, Synucleinopathies, Disease Models, Animal, Biomarkers. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: CIHR, BrainsCAN/Healthy Brains, Healthy Lives, Fonds de Recherche du Québec - Santé.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Significant evidence suggests that misfolded alpha‐synuclein (aSyn), a major component of Lewy bodies, propagates in a prion‐like manner contributing to disease progression in Parkinson's disease (PD) and other synucleinopathies. In fact, timed inoculation of M83 hemizygous mice with recombinant human aSyn preformed fibrils (PFF) has shown symptomatic deficits after substantial spreading of pathogenic alpha‐synuclein, as detected by markers for the phosphorylation of S129 of aSyn. However, whether accumulated toxicity impact human‐relevant cognitive and structural neuroanatomical measures is not fully understood. Here we performed a single unilateral striatal PFF injection in M83 hemizygous mice, and using two assays with translational potential, ex vivo magnetic resonance imaging (MRI) and touchscreen testing, we examined the combined neuroanatomical and behavioral impact of aSyn propagation. In PFF‐injected mice, we observed widespread atrophy in bilateral regions that project to or receive input from the injection site using MRI. We also identified early deficits in reversal learning prior to the emergence of motor symptoms. Our findings highlight a network of regions with related cellular correlates of pathology that follow the progression of aSyn spreading, and that affect brain areas relevant for reversal learning. Our experiments suggest that M83 hemizygous mice injected with human PFF provides a model to understand how misfolded aSyn affects human‐relevant pre‐clinical measures and suggest that these pre‐clinical biomarkers could be used to detect early toxicity of aSyn and provide better translational measures between mice and human disease. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

alpha-SynucleinSynucleinopathiesDisease Models, AnimalBiomarkersAnimalsMiceHumansMagnetic Resonance ImagingMaleFemaleCognitionMice, TransgenicReversal Learning

Stichwörter der Autor:innen

MRIalpha‐synucleincognitionmouse modelneurodegenerationtouchscreen

Substanzen

alpha-SynucleinBiomarkers

Autor:innen und Institutionen

  • Integrated Program in Neuroscience, McGill University, Montreal, Quebec, Canada.
  • Computational Brain Anatomy (CoBrA) Laboratory, Cerebral Imaging Center, Douglas Mental Health University Institute, McGill University, Verdun, Quebec, Canada.
  • Robarts Research Institute, Schulich School of Medicine and Dentistry, The University of Western Ontario, London, Ontario, Canada.
  • Departamento de Morfologia, Instituto de Ciencias Biologicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
  • McGill Parkinson Program, Neurodegenerative Diseases Group, Department of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital, McGill University, Montreal, Quebec, Canada.
  • Department of Biological & Biomedical Engineering, McGill University, Montreal, Quebec, Canada.

ORCID-Profile: Stephanie Tullo, Marco A M Prado

Förderung

  • CIHR
  • BrainsCAN/Healthy Brains, Healthy Lives
  • Fonds de Recherche du Québec - Santé
  • Healthy Brains, Healthy Lives
  • Natural Science and Engineering Research Council of Canada
  • Rodent Cognitive and Innovation Core
  • The Tanenbaum Open Science Institute
  • Canadian Institutes of Health Research

Zitieren

APA

Tullo, S., Miranda, A. S., Del Cid-Pellitero, E., Lim, M. P., Gallino, D., Attaran, A., Patel, R., Novikov, V., Park, M., Beraldo, F. H., Luo, W., Shlaifer, I., Durcan, T. M., Bussey, T. J., Saksida, L. M., Fon, E. A., Prado, V. F., Prado, M. A. M., & Chakravarty, M. M. (2024). Neuroanatomical and cognitive biomarkers of alpha‐synuclein propagation in a mouse model of synucleinopathy prior to onset of motor symptoms. Journal of Neurochemistry. https://doi.org/10.1111/jnc.15967

Vancouver

Tullo S, Miranda AS, Del Cid-Pellitero E, Lim MP, Gallino D, Attaran A, et al. Neuroanatomical and cognitive biomarkers of alpha‐synuclein propagation in a mouse model of synucleinopathy prior to onset of motor symptoms. Journal of Neurochemistry. 2024. doi:10.1111/jnc.15967

BibTeX
@article{Tullo2024,
  author = {Tullo, Stephanie and Miranda, Aline S and Del Cid-Pellitero, Esther and Lim, Mei Peng and Gallino, Daniel and Attaran, Anoosha and Patel, Raihaan and Novikov, Vladislav and Park, Megan and Beraldo, Flavio H and Luo, Wen and Shlaifer, Irina and Durcan, Thomas M and Bussey, Timothy J and Saksida, Lisa M and Fon, Edward A and Prado, Vania F and Prado, Marco A M and Chakravarty, M Mallar},
  title = {Neuroanatomical and cognitive biomarkers of alpha‐synuclein propagation in a mouse model of synucleinopathy prior to onset of motor symptoms},
  journal = {Journal of Neurochemistry},
  year = {2024},
  doi = {10.1111/jnc.15967}
}
Kostenlos starten →